Pitavastatin Calcium

匹伐他汀钙

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePitavastatin Calcium
Drug Alias Name匹他伐他汀PitavastatinaPitavastatinum匹妥伐他汀Pitavastatine +[23] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHMG-CoA reductase inhibitors
TargetsHMG-CoA reductase
Therapy Area/IndicationsHypercholesterolemiaHyperlipidemiasDyslipidemias +[4] 
Global Approved IndicationsHypercholesterolemiaHyperlipidemiasDyslipidemias +[4] 
Approved Indications in ChinaHypercholesterolemiaHyperlipidemiasDyslipidemias
Original Approved Country/TerritoryJapan
Original Approved Date2003/07/17
Country/TerritoryUnited StatesSwedenNetherlands +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNissan Chemical Corp
China Registration ClassN/A

Develop Information

Active CompaniesKowa Dental Health Co Ltd
Inactive CompaniesKowa Research Europe LtdKowa Research Institute Inc
Active IndicationsHypercholesterolemiaHyperlipidemiasDyslipidemias +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeC10AA08
Related LinksWikipediaDrugBankKEGG